基于网络分块调控分析的组学数据癌症异质性建模
该研究提出一种新的惩罚方法,同时识别样本分组并估计调控因子的分块结构、组特异性网络及调控关系,理论证明其估计、选择与分块识别的一致性;模拟研究显示其优于多种替代方法,并在TCGA乳腺癌数据中基于基因表达与蛋白表达双组学数据得到与替代方法不同的合理发现。
要点
- 新方法同时识别样本分组与调控因子分块结构,提升异质性分析。
- 理论证明估计、选择与分块识别具有一致性。
- 模拟研究显示方法优于多种替代方法。
核心结论
- 所提惩罚方法可同时识别样本分组并估计分块结构、组特异性网络及调控关系,且具有估计、选择与分块识别的一致性。
研究设计与样本
- 方法学研究,开发惩罚方法、计算算法,并通过模拟研究与TCGA乳腺癌数据分析验证。
主要发现
- 模拟研究中该方法相对于多种替代方法具有竞争力。
- TCGA乳腺癌数据中基于基因表达与蛋白表达双组学分析得到与替代方法不同的合理发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Omics data have been extensively analyzed to quantify the heterogeneity of cancer and other diseases. Recent studies have suggested that interconnections among omics variables, as reflected in network structures, can be more informative than simpler measures. Multiple types of omics variables can be connected via regulatory relationships, and there are studies modeling heterogeneity based on such regulations. Here, we conduct heterogeneity analysis based on both network structures and regulatory relationships. Significantly different from the existing literature, we consider network structures of regulators, as opposed to regulatees-such networks describe more essential biological mechanisms and are less likely to be blurred by the mixture of direct and indirect interconnections. Another significant advancement is that we incorporate (unknown) blocking structures of regulators, which contain information complementary to network structures. A novel penalization approach is developed to simultaneously identify sample groups and estimate block structures, group-specific networks, and regulation relationships. An effective computational algorithm is developed. It is rigorously proved that the proposed approach enjoys consistency in estimation, selection, and block identification. Simulation studies demonstrate its competitiveness against multiple alternatives. In the analysis of TCGA breast cancer data, we consider the (gene expression, protein expression) dual and make sensible findings that differ from those of the alternatives.
引用
- Li R, Ma S. Cancer Heterogeneity Modeling With Omics Data via Network-Based Block-Wise Regulatory Analysis. Stat Med. 2026. PMID: 42875016. doi:10.1002/sim.70779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。